155 related articles for article (PubMed ID: 38834774)
1. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer.
Shi W; Xu C; Lei P; Sun X; Song M; Guo Y; Song W; Li Y; Yu L; Zhang H; Wang H; Zhang DL
Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38834774
[TBL] [Abstract][Full Text] [Related]
2. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer.
Lei P; Wang H; Yu L; Xu C; Sun H; Lyu Y; Li L; Zhang DL
Int Immunopharmacol; 2022 Jul; 108():108743. PubMed ID: 35413679
[TBL] [Abstract][Full Text] [Related]
3. International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.
Hamann J; Aust G; Araç D; Engel FB; Formstone C; Fredriksson R; Hall RA; Harty BL; Kirchhoff C; Knapp B; Krishnan A; Liebscher I; Lin HH; Martinelli DC; Monk KR; Peeters MC; Piao X; Prömel S; Schöneberg T; Schwartz TW; Singer K; Stacey M; Ushkaryov YA; Vallon M; Wolfrum U; Wright MW; Xu L; Langenhan T; Schiöth HB
Pharmacol Rev; 2015; 67(2):338-67. PubMed ID: 25713288
[TBL] [Abstract][Full Text] [Related]
4. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
Liu F; Wu H
J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
[TBL] [Abstract][Full Text] [Related]
5. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
Liu F; Wu H
J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
[TBL] [Abstract][Full Text] [Related]
6. Mining the prognostic significance and immune infiltration of
Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
[TBL] [Abstract][Full Text] [Related]
7. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer.
Cheng T; Chen P; Chen J; Deng Y; Huang C
Front Genet; 2021; 12():809600. PubMed ID: 35069702
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic indicators, diagnostic markers, and possible therapeutic targets among LIM homeobox transcription factors in breast cancer.
Gao P; Sun N; Zhao T; Sun Y; Gu J; Ma D; Tian H; Peng Z; Zhang Y; Han F; Qi X
Cancer Innov; 2022 Oct; 1(3):252-269. PubMed ID: 38089759
[TBL] [Abstract][Full Text] [Related]
9. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer.
Mei J; Hao L; Liu X; Sun G; Xu R; Wang H; Liu C
Biomark Res; 2019; 7():16. PubMed ID: 31402980
[TBL] [Abstract][Full Text] [Related]
11. Characterization of upregulated adhesion GPCRs in acute myeloid leukemia.
Yang J; Wu S; Alachkar H
Transl Res; 2019 Oct; 212():26-35. PubMed ID: 31153896
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of the Associations of LOXL1-4 with Prognosis and Immune Infiltration in Breast Cancer.
He L; Lin Y; Huang P; Pan H
Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518152
[TBL] [Abstract][Full Text] [Related]
13. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
Ling J; Peng N; Luo L
J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
[TBL] [Abstract][Full Text] [Related]
14. ADGRF4 Regulates Non-small Cell Lung Cancer Cell Invasiveness.
Yoon JH; Cho SG
Anticancer Res; 2020 Dec; 40(12):6835-6844. PubMed ID: 33288575
[TBL] [Abstract][Full Text] [Related]
15. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
[TBL] [Abstract][Full Text] [Related]
16. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.
Li L; Li S; Zhang X; Mei L; Fu X; Dai M; Wei N
Aging (Albany NY); 2024 Jan; 16(2):1077-1095. PubMed ID: 38224491
[TBL] [Abstract][Full Text] [Related]
17. Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis.
Yang Y; Li F; Luo X; Jia B; Zhao X; Liu B; Gao R; Yang L; Wei W; He J
DNA Cell Biol; 2019 Oct; 38(10):1088-1099. PubMed ID: 31424267
[TBL] [Abstract][Full Text] [Related]
18. Tethered peptide activation mechanism of the adhesion GPCRs ADGRG2 and ADGRG4.
Xiao P; Guo S; Wen X; He QT; Lin H; Huang SM; Gou L; Zhang C; Yang Z; Zhong YN; Yang CC; Li Y; Gong Z; Tao XN; Yang ZS; Lu Y; Li SL; He JY; Wang C; Zhang L; Kong L; Sun JP; Yu X
Nature; 2022 Apr; 604(7907):771-778. PubMed ID: 35418677
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of ACKR family members in breast cancer using prognostic values.
Yang L; Zhang S; Pu P
Oncol Lett; 2023 Oct; 26(4):425. PubMed ID: 37664667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
